SCHEMBL7322942

SCHEMBL7322942

CCOC(=O)CC(c1ccccc1)N1CC(=O)N(C)c2ccc(C#CCCOc3cccnc3NC(=O)OC(C)(C)C)cc2C1=O

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
TP53 P04637 2/20 0.36
ITGB3 P05106 3/20 0.36
ITGA2B P08514 3/20 0.36
HDAC1 Q13547 3/20 0.34
HDAC6 Q9UBN7 2/20 0.34
GABRA1 P14867 3/20 0.33
GABRG2 P18507 3/20 0.33
GABRB3 P28472 3/20 0.33
GABRA5 P31644 3/20 0.33
GABRA3 P34903 3/20 0.33
GABRA2 P47869 3/20 0.33
GABRA6 Q16445 3/20 0.33
RIPK1 Q13546 4/20 0.32
GABRB2 P47870 2/20 0.31
GABRA4 P48169 2/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7325293 0.93 MEN1 (0.36) MEN1KMT2ATP53ITGB3ITGA2B
SCHEMBL7330383 0.93 MEN1 (0.35) MEN1KMT2ATP53ITGB3ITGA2B
SCHEMBL7332371 0.92 ITGB3 (0.41) MEN1KMT2ATP53ITGB3ITGA2B
SCHEMBL7323775 0.92 MEN1 (0.35) MEN1KMT2ATP53GABRA1GABRG2
SCHEMBL7325193 0.87 MEN1 (0.37) MEN1KMT2ATP53GABRA1GABRG2
SCHEMBL7330784 0.86 RIPK1 (0.34) HDAC1HDAC6RIPK1
SCHEMBL8842892 0.86 ITGB3 (0.35) MEN1KMT2ATP53ITGB3ITGA2B
SCHEMBL8842887 0.86 ITGB3 (0.35) MEN1KMT2ATP53ITGB3ITGA2B
SCHEMBL7321894 0.85 ITGB3 (0.35) MEN1KMT2ATP53ITGB3ITGA2B
SCHEMBL7333049 0.83 ITGB3 (0.40) ITGB3ITGA2BHDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663166-A ANTICOAGULANTS OF 1,4-BENZODIAZEPINE-2,5-DIONE AND 2-BENZOAZEPINE-1,4-DIONE DERIVATIVES; PREVENTS FIBRINOGEN BINDING NECESSARY FOR PLATELET AGGREGATION; SIDE EFFECT REDUCTION, E.G. EXCESSIVE BLEEDING GENENTECH, INC. (US) 1997-09-02 US disclosed
US-5565449-A PLATELET AGGREGATION INHIBITORS GENENTECH, INC. (US) 1996-10-15 US disclosed
EP-0610334-B1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPII B III A RECEPTOR GENENTECH INC (US) 1996-01-24 EP disclosed
US-5403836-A Anticoagulants GENENTECH, INC. (US) 1995-04-04 US disclosed
EP-0610334-A1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPII b?III a? RECEPTOR. GENENTECH INC (US) 1994-08-17 EP disclosed
US-5250679-A Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor GENENTECH, INC. (US) 1993-10-05 US disclosed
WO-1993008174-A1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPIIbIIIa RECEPTOR GENENTECH, INC. (US) 1993-04-29 WO disclosed